AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26564292 — intervention group
Group type: COMPARATOR
Intervention: 10% povidone‐iodine
Number of subjects: 388
Study 24289099 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based guided self-help treatment
Number of subjects: 0
Study 24289099 — intervention group
Group type: COMPARATOR
Intervention: Self-help book
Number of subjects: 0
Study 21244861 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 0
Study 21244861 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 19303145 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire (SAQ)
Number of subjects: 1495
Study 19303145 — intervention group
Group type: EXPERIMENTAL
Intervention: SAQ with audio (AASI)
Number of subjects: 1495
Study 19303145 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered questionnaire (IAQ)
Number of subjects: 1495
Study 19303145 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio computer-assisted survey instrument (ACASI)
Number of subjects: 1495
Study 17402320 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy targeting glucose at 110‐140 mg/dl
Number of subjects: 89
Study 17402320 — intervention group
Group type: COMPARATOR
Intervention: Conventional insulin therapy controlling glucose at 140‐200 mg/dl when exceeding 200 mg/dl
Number of subjects: 89
Study 15488058 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.75%
Number of subjects: 45
Study 15488058 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine 0.5%
Number of subjects: 45
Study 11210405 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 60 mg daily for 8 days + Almotriptan 12.5 mg on Day 8
Number of subjects: 14
Study 11210405 — intervention group
Group type: COMPARATOR
Intervention: Almotriptan 12.5 mg on Day 8
Number of subjects: 14
Study 10194994 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (20 mg/kg)
Number of subjects: 75
Study 10194994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 7845558 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantomimed movements directed towards remembered objects
Number of subjects: 0
Study 7845558 — intervention group
Group type: COMPARATOR
Intervention: Natural target-directed grasping movements
Number of subjects: 0
Study 7845558 — intervention group
Group type: EXPERIMENTAL
Intervention: Pantomimed actions beside a target object
Number of subjects: 0
Study 7845558 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagined, familiar objects
Number of subjects: 0
Study 3051607 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month regimen of rifampicin and ethambutol (4RE) supplemented by streptomycin and pyrazinamide for the first 2 months
Number of subjects: 226
Study 3051607 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month regimen of rifampicin and ethambutol (7RE) supplemented by streptomycin and pyrazinamide for the first 2 months
Number of subjects: 226
Study 31738228 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline + Morphine combination therapy
Number of subjects: 24
Study 31738228 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 24
Study 31738228 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 24
Study 31037274 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (20 IU twice daily)
Number of subjects: 28
Study 31037274 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 28160545 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (TG)
Number of subjects: 26
Study 28160545 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 26
Study 26162657 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychodynamic psychotherapy (SPP)
Number of subjects: 326
Study 26162657 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term psychodynamic psychotherapy (LPP)
Number of subjects: 326
Study 26162657 — intervention group
Group type: EXPERIMENTAL
Intervention: Solution-focused therapy (SFT)
Number of subjects: 326
Study 26162657 — intervention group
Group type: COMPARATOR
Intervention: Short-term therapies (SPP and SFT)
Number of subjects: 326
Study 23451806 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily prolonged-release mesalazine (4 g/day)
Number of subjects: 206
Study 23451806 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily prolonged-release mesalazine (4 g/day)
Number of subjects: 206
Study 21640780 — intervention group
Group type: EXPERIMENTAL
Intervention: RIX4414
Number of subjects: 100
Study 18405442 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted agents targeting the hypoxia inducible factor-alfa (HIF-) / vascular endothelial growth factor (VEGF) pathway and mammalian target of rapamycin (mTOR) signal transduction pathway
Number of subjects: 0
Study 18405442 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0
Study 17786805 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants in the intervention (education of municipality employees)
Number of subjects: 5788
Study 17786805 — intervention group
Group type: COMPARATOR
Intervention: Non-participants
Number of subjects: 5788
Study 17786805 — intervention group
Group type: COMPARATOR
Intervention: Subgroups of non-participants (too ill, not reached)
Number of subjects: 5788
Study 17786805 — intervention group
Group type: COMPARATOR
Intervention: Subgroups of non-participants (too healthy, another reason for refusal)
Number of subjects: 5788
Study 17786805 — intervention group
Group type: COMPARATOR
Intervention: Non-participants in intervention municipalities
Number of subjects: 5788
Study 15273470 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) 0.05 mg/kg/day for 1 year
Number of subjects: 30
Study 15273470 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing mode with optimized AVD
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: VVI pacing mode
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal DDD pacing mode
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: VVI pacing mode in CAD and AH + CAD patients
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: Conversion from VVI to optimal DDD pacing mode
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing mode
Number of subjects: 60
Study 11475854 — intervention group
Group type: EXPERIMENTAL
Intervention: CAD patients with myocardial infarction or AH patients with LV hypertrophy
Number of subjects: 60
Study 11475854 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 10101926 — intervention group
Group type: COMPARATOR
Intervention: Laser Doppler fluxmetry
Number of subjects: 67
Study 7937568 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg clobazam
Number of subjects: 21
Study 2965154 — intervention group
Group type: EXPERIMENTAL
Intervention: rIFN alpha 2C (2MU) given subcutaneously 5 times per week for 8-12 weeks, then once weekly until week 48.
Number of subjects: 93
Study 2965154 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy of rIFN alpha 2C (2MU) and medroxyprogesterone acetate (MPA) 750 mg p.o. daily until week 48.
Number of subjects: 93
Study 2965154 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned, but both treatment groups had a median survival of 7 months.
Number of subjects: 93
Study 31573856 — intervention group
Group type: EXPERIMENTAL
Intervention: Trocar technique
Number of subjects: 105
Study 31573856 — intervention group
Group type: COMPARATOR
Intervention: Seldinger technique
Number of subjects: 105
Study 29649897 — intervention group
Group type: EXPERIMENTAL
Intervention: Community assets (2 assets)
Number of subjects: 1111
Study 29649897 — intervention group
Group type: EXPERIMENTAL
Intervention: Community assets (3 assets)
Number of subjects: 1111
Study 29649897 — intervention group
Group type: EXPERIMENTAL
Intervention: Community assets (4 to 5 assets)
Number of subjects: 1111
Study 29649897 — intervention group
Group type: COMPARATOR
Intervention: 0 to 1 assets
Number of subjects: 1111
Study 26477350 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-specific play therapy intervention
Number of subjects: 79
Study 26477350 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 79
Study 24594090 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel supraglottic airway (IG-SGA)
Number of subjects: 51
Study 24594090 — intervention group
Group type: COMPARATOR
Intervention: Portex Soft Seal Laryngeal Mask (PSS-LM)
Number of subjects: 51
Study 22744207 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient long-term treatment
Number of subjects: 40
Study 22744207 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 20412877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal vaccination (0.2 ml, 6 microg HA per strain, split into two-site injections)
Number of subjects: 156
Study 20412877 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular vaccination (0.5 ml, 15 microg HA per strain)
Number of subjects: 156
Study 18546660 — intervention group
Group type: EXPERIMENTAL
Intervention: Tilted ellipses depicting the circular top of a cylinder at angles from 5 degrees to 85 degrees.
Number of subjects: 0
Study 15957833 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptolide (TL) plus benazepril
Number of subjects: 67
Study 15957833 — intervention group
Group type: COMPARATOR
Intervention: Benazepril alone
Number of subjects: 67
Study 12235694 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 41
Study 12235694 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 months after cessation of chemotherapy
Number of subjects: 41
Study 10421395 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition alone
Number of subjects: 92
Study 10421395 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition plus chemotherapy
Number of subjects: 92
Study 10421395 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy alone
Number of subjects: 92
Study 10421395 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 92
Study 7669306 — intervention group
Group type: EXPERIMENTAL
Intervention: End-tidal isoflurane monitored (n = 60)
Number of subjects: 120
Study 7669306 — intervention group
Group type: COMPARATOR
Intervention: Unmonitored group (n = 60)
Number of subjects: 120
Study 7669306 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study 2160490 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (15 capsules of 1 g fish oil daily)
Number of subjects: 20
Study 2160490 — intervention group
Group type: COMPARATOR
Intervention: Olive oil control (15 capsules of 1 g olive oil daily)
Number of subjects: 20
Study 433814 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinfandel wine (9.3% w/v alcohol)
Number of subjects: 6
Study 433814 — intervention group
Group type: EXPERIMENTAL
Intervention: Delacholized Zinfandel wine
Number of subjects: 6
Study 433814 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure ethanol (9.3% w/v aqueous solution)
Number of subjects: 6
Study 433814 — intervention group
Group type: COMPARATOR
Intervention: Deionized water
Number of subjects: 6
Study 29961138 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF + HA
Number of subjects: 30
Study 29961138 — intervention group
Group type: COMPARATOR
Intervention: CAF alone
Number of subjects: 30
Study 27928660 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based case management in addition to usual care
Number of subjects: 150
Study 27928660 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study 25996365 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spinal manipulative therapy (SMT)
Number of subjects: 52
Study 25996365 — intervention group
Group type: COMPARATOR
Intervention: Sham SMT
Number of subjects: 52
Study 25996365 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SMT and sham SMT)
Number of subjects: 52
Study 23761412 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-message reminder
Number of subjects: 991
Study 23761412 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text-message reminder)
Number of subjects: 991
Study 21646287 — intervention group
Group type: EXPERIMENTAL
Intervention: Phlebotomy therapy
Number of subjects: 50
Study 21646287 — intervention group
Group type: COMPARATOR
Intervention: Normal care
Number of subjects: 50
Study 19860612 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly methotrexate (MTX) and daily 6-mercaptopurine maintenance therapy
Number of subjects: 49
Study 19860612 — intervention group
Group type: EXPERIMENTAL
Intervention: Random determination of serum MTX levels
Number of subjects: 49
Study 18092436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal Midazolam 0.2 mg/kg
Number of subjects: 50
Study 18092436 — intervention group
Group type: COMPARATOR
Intervention: Intranasal Ketamine 5 mg/kg
Number of subjects: 50
Study 15139159 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Recovery (ACT) - running at 40% PRS for 15 minutes after the first pair of treadmill runs
Number of subjects: 14
Study 15139159 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast Temperature Water Immersion (CTW) - alternating between 60-s cold (10 degrees C) and 120-s hot (42 degrees C) water immersion for 15 minutes after the first pair of treadmill runs
Number of subjects: 14
Study 15139159 — intervention group
Group type: COMPARATOR
Intervention: Passive Recovery (PAS) - standing stationary for 15 minutes after the first pair of treadmill runs
Number of subjects: 14
Study 11602864 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. ganciclovir
Number of subjects: 12
Study 11602864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 9641128 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 200
Study 9641128 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide (Control)
Number of subjects: 200
Study 7857503 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypericum extract (3 x 300 mg)
Number of subjects: 102
Study 7857503 — intervention group
Group type: COMPARATOR
Intervention: Maprotiline (3 x 25 mg)
Number of subjects: 102
Study 2573178 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaxolol 10 mg
Number of subjects: 24
Study 2573178 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg
Number of subjects: 24
Study 870015 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracameral injection of 50 microng of gentamicin
Number of subjects: 1626
Study 870015 — intervention group
Group type: COMPARATOR
Intervention: Systemic and topical chloramphenicol prophylaxis (historical control)
Number of subjects: 1626
Study 31856835 — intervention group
Group type: EXPERIMENTAL
Intervention: Doorstep provision of oral contraceptive pills and condoms
Number of subjects: 3078
Study 28437597 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers Online (WWO)
Number of subjects: 279
Study 28437597 — intervention group
Group type: COMPARATOR
Intervention: Control (online newsletter)
Number of subjects: 279
Study 28437597 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers Online with ActiveLink (WWO+AL)
Number of subjects: 279
Study 25971607 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 234
Study 25971607 — intervention group
Group type: COMPARATOR
Intervention: Surgical repair
Number of subjects: 234
Study 24658396 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS (1 Hz cerebellar rTMS, 5 sessions of 15 minutes over 5 days)
Number of subjects: 32
Study 24658396 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 32
Study 22244705 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention for alcohol dependence (12 weeks)
Number of subjects: 77
Study 19930331 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin
Number of subjects: 751
Study 19930331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 751
Study 17560287 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (ENOX)
Number of subjects: 4676
Study 17560287 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 4676
Study 15552358 — intervention group
Group type: EXPERIMENTAL
Intervention: Generation (self-produced items)
Number of subjects: 0
Study 15552358 — intervention group
Group type: COMPARATOR
Intervention: Provided items (control)
Number of subjects: 0
Study 11906445 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual expression (importance rated by patients)
Number of subjects: 112
Study 9477042 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg (2 tab/day)
Number of subjects: 77
Study 9477042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 9477042 — intervention group
Group type: EXPERIMENTAL
Intervention: Daflon 500 mg
Number of subjects: 77
Study 7873471 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine (200 or 500 micrograms/kg body weight)
Number of subjects: 15
Study 3060511 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical glucocorticosteroids (budesonide, 100 micrograms in each nasal cavity every 12 hours)
Number of subjects: 10
Study 3060511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 28459795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise (NHE) program, 4 weeks, twice a week, 3 sets of 6-10 repetitions
Number of subjects: 20
Study 28459795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic hamstring exercise (NHE) program
Number of subjects: 20
Study 28459795 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 20
Study 28628003 — intervention group
Group type: COMPARATOR
Intervention: FCR (fludarabine, cyclophosphamide, and rituximab)
Number of subjects: 206
Study 28628003 — intervention group
Group type: EXPERIMENTAL
Intervention: FCM-miniR (fludarabine, cyclophosphamide, mitoxantrone, and low-dose rituximab)
Number of subjects: 206
Study 28628003 — intervention group
Group type: COMPARATOR
Intervention: FCR
Number of subjects: 206
Study 28628003 — intervention group
Group type: EXPERIMENTAL
Intervention: FCM-miniR
Number of subjects: 206
Study 28628003 — intervention group
Group type: EXPERIMENTAL
Intervention: FCR and FCM-miniR
Number of subjects: 206
Study 26641632 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based exam
Number of subjects: 0
Study 26641632 — intervention group
Group type: COMPARATOR
Intervention: Paper-based exam
Number of subjects: 0
Study 21172506 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic mitral regurgitation group (IMR)
Number of subjects: 35
Study 21172506 — intervention group
Group type: COMPARATOR
Intervention: Normal mitral valve group (Control)
Number of subjects: 35
Study 21172506 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic mitral regurgitation group (IMR) with anterior infarct
Number of subjects: 35
Study 21172506 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic mitral regurgitation group (IMR) with inferior infarct
Number of subjects: 35
Study 18926439 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 255
Study 16735174 — intervention group
Group type: COMPARATOR
Intervention: Metabolite ratio (citrate/(choline+creatine)) and ADC values in patients with PSA >20 ng/ml (Group II)
Number of subjects: 40
Study 16735174 — intervention group
Group type: COMPARATOR
Intervention: Metabolite ratio and ADC values in patients with PSA 4-20 ng/ml (Group III)
Number of subjects: 40
Study 16735174 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance (MR) imaging
Number of subjects: 40
Study 16735174 — intervention group
Group type: COMPARATOR
Intervention: TRUS-guided biopsy
Number of subjects: 40
Study 14585635 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed-dye laser (PDL) treatment
Number of subjects: 41
Study 14585635 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 41
Study 15277588 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted Project Northland intervention
Number of subjects: 0
Study 15277588 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 10466240 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant RT started within 4 weeks after breast surgery
Number of subjects: 0
Study 10466240 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant RT started after a delay of up to 8 weeks
Number of subjects: 0
Study 10466240 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous tissue transfer for breast reconstruction after mastectomy and adjuvant RT
Number of subjects: 0
Study 10466240 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate reconstruction before RT or delayed reconstruction after RT using TRAM procedure
Number of subjects: 0
Study 8626878 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose amlodipine 2.5 mg daily
Number of subjects: 401
Study 8626878 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose benazepril 10 mg daily
Number of subjects: 401
Study 8626878 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of amlodipine 2.5 mg and benazepril 10 mg daily
Number of subjects: 401
Study 8626878 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine and benazepril regimen
Number of subjects: 401
Study 2399132 — intervention group
Group type: EXPERIMENTAL
Intervention: Extremity wraps
Number of subjects: 40
Study 2399132 — intervention group
Group type: COMPARATOR
Intervention: Control (no extremity wraps)
Number of subjects: 40
Study 2399132 — intervention group
Group type: EXPERIMENTAL
Intervention: Shivering
Number of subjects: 40
Study 120078 — intervention group
Group type: EXPERIMENTAL
Intervention: pindolol
Number of subjects: 68
Study 120078 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 68
Study 30642308 — intervention group
Group type: EXPERIMENTAL
Intervention: Early medication change (EMC) strategy with immediate switch to high doses of venlafaxine XR
Number of subjects: 192